HSPA9 and ovarian carcinoma: We found in this study that GRP75 knockdown or inhibition suppresses the ubiquitination and degradation of both exogenous GST-proto-Dbl in Cos-7 cells and endogenous proto-Dbl in ovarian cancer cells (Figs. 4, 5c, d and 6).